Hilgendorf, I. (2025). Impfungen bei immunsupprimierten Patienten. In: Schmoll, HJ. (eds) Kompendium Internistische Onkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46764-0_309-1

A.-K. Köditz, A. Mehnert-Theuerkauf, U. Platzbecker, A. Hochhaus, M. Jentzsch, G.-N. Franke, I. Hilgendorf, J. Ernst: Therapieadhärenz bei Patienten mit Stammzelltransplantation bei einer hämatologischen Krebserkrankung (TASK) – eine bizentrische Beobachtungstudie. Forum 40, 426–428 (2025). https://doi.org/10.1007/s12312-025-01496-0

Cortes JE, Hughes TP, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Etienne G, Kim I, Andorsky D, Bombaci F, Issa GC, Takahashi N, Kapoor S, Jinwal R, Malek K, McCulloch T, Yau L, Larson RA, Hochhaus A. Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial. Blood. 2025 Dec 15:blood.2025029210. doi: 10.1182/blood.2025029210. Epub ahead of print. PMID: 41397287

Gale RP, Hochhaus A. Things that drive Editors crazy: jargon, unnecessary abbreviations, abusing decimals and a few more. Leukemia. 2025 Dec 10. doi: 10.1038/s41375-025-02838-6. Epub ahead of print. PMID: 4137259

Cuker A, Stauch T, Cooper N, Al-Samkari H, Michel M, Ghanima W, Urban P, Fronczek J, Foster M, Weill M, Zhang L, Hou M, Zander T, Sharif A, Sun J, Nath UK, Schutgens R, Rossi E, Deleu L, Červinek L, Yoon JH, Chang H, Ruchutrakool T, Iino M, Goto T, Zaja F; VAYHIT2 Investigators. Ianalumab plus Eltrombopag in Immune Thrombocytopenia. N Engl J Med. 2025 Dec 9. doi: 10.1056/NEJMoa2515168. Epub ahead of print. PMID: 41363800

Tintelnot J, Paschold L, Goekkurt E, Schultheiss C, Matschl U, Santos Cruz M, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich TJ, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Bokemeyer C, Sinn M, Lindig U, Hinke A, Hegewisch-Becker S, Stein A, Binder M. Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy. Cancer Immunol Res. 2025 Feb 3;13(2):200-209. doi: 10.1158/2326-6066.CIR-24-0561. PMID: 39527097; PMCID: PMC11788649

Gerhardt F, Müller C, Venerito M, Chater J, Mohr R, Egerer M, Lindig U, Schindler A, Ebel S, Fischer J, Schwarz M, Gehring S, Berg T, van Bömmel F. Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient population. J Cancer Res Clin Oncol. 2025 Jun 18;151(6):191. doi: 10.1007/s00432-025-06239-1. PMID: 40533571; PMCID: PMC12176970

Hübner J: Was können und müssen wir aus den Erfolgsgeschichten der Alternativen Medizin lernen? Überzeugungskräfte, Über das Vertrauen in Wissenschaft (und Pseudowissenschaft), Herausgeber:innen: Mathis Lessau  und Hans Christian Riechers; Kartoniert, Status: Publiziert, ISBN: 978-3-7705-6932-8, Publikation: 07 Nov 2025

Ulf Schnetzke , David Irvine, José Mário Mariz, P. Joy Ho. How I Treat: Improving Patient Outcomes With Real-World Evidence in R/R DLBCL. Medscape Medical Affairs, Novartis, Industry sponsored scientific communication. Content ID: FA-11397715. October 2025

Göllner S, Oellerich T, Agrawal-Singh S, Schenk T, Klein HU, Rohde C, Pabst C, Sauer T, Lerdrup M, Tavor S, Stölzel F, Herold S, Ehninger G, Köhler G, Pan KT, Urlaub H, Serve H, Dugas M, Spiekermann K, Vick B, Jeremias I, Berdel WE, Hansen K, Zelent A, Wickenhauser C, Müller LP, Thiede C, Müller-Tidow C. Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. Nat Med. 2017 Jan;23(1):69-78. doi: 10.1038/nm.4247. Epub 2016 Dec 12. PMID: 27941792; PMCID: PMC6548550

Hentze, A., Keinki, C., Walter, S. et al. Demographic and biographical data from cancer patients of a German online self-help forum. J Public Health (Berl.) (2025). https://doi.org/10.1007/s10389-025-02608-9

Rauchfuß F, Schwenk L, Dondorf F, Rohland O, Ali-Deeb A, Hochhaus A, Settmacher U. Liver transplantation in well-selected patients with unresectable colorectal liver metastases. Liver Transpl. 2025 Sep 25. doi: 10.1097/LVT.0000000000000739. Epub ahead of print. PMID: 40990644

Käsmann L, Gurtner R, Rennollet R, Büntzel J, Micke O, Belka C, Pazos M, Mücke R, Rauch J, Hübner J. Complementary and Alternative Medicine (CAM) Use in Patients Undergoing Radiotherapy: Sex-specific Prevalence and Associations of Use Based on the S3 Guideline Complementary Medicine in Oncology Questionnaire. In Vivo. 2025 Sep-Oct;39(5):2969-2975. doi: 10.21873/invivo.14097. PMID: 40877141; PMCID: PMC12396048

Gale RP, Hochhaus A. Are real world data real world data? Leukemia. 2025 Oct;39(10):2311-2312. doi: 10.1038/s41375-025-02751-y. Epub 2025 Sep 11. PMID: 40935824

Nagel SN, Brintrup J, Ghannam Y, Stallmach A, Hochhaus A, Ripoll C, Cario H, Schrenk KG. Combined heterozygosity for the highly unstable variant hemoglobin Taybe, and α-thalassemia as a rare cause of hemolytic anemia. Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06578-6. Epub ahead of print. PMID: 40924176

Curik N, Laznicka A, Krizkova J, Suchankova P, Vavrova A, Polivkova V, Pokorna E, Semerak P, Burda P, Kuzilkova D, Kalina T, Hochhaus A, Machova Polakova K. Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia. Leukemia. 2025 Oct;39(10):2555-2558. doi: 10.1038/s41375-025-02732-1. Epub 2025 Aug 26. PMID: 40858806; PMCID: PMC12463652

Kemmner SF, Dörfler J, Huebner J. Cannabinoids for the prevention of chemotherapy-induced nausea and vomiting in oncological therapy: a systematic review. J Cancer Surviv. 2025 Aug 12. doi: 10.1007/s11764-025-01876-4. Epub ahead of print. PMID: 4079706

Bröckelmann PJ, Böll B, Molin D, Schneider G, Leppä S, Meissner J, Kamper P, Hutchings M, Christensen JH, Schnetzke U, Fuchs M, Jablonski J, Eichenauer DA, von Tresckow B, Klapper W, Kobe C, Borchmann P, Fosså A. Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients. Hemasphere. 2025 Aug 18;9(8):e70190. doi: 10.1002/hem3.70190. PMID: 40832013; PMCID: PMC12358935

Ciarlo G, Josfeld L, Muenstedt K, Micke O, Buentzel J, Zomorodbakhsch B, Klein M, Keinki C, Huebner J. Evidence-Based Medicine and Complementary and Alternative Medicine - Attitudes and Knowledge of German Medical Students. Cancer Invest. 2025 Aug 5:1-8. doi: 10.1080/07357907.2025.2543850. Epub ahead of print. PMID: 40764257

Limbrunner J, Doerfler J, Pietschmann K, Buentzel J, Scharpenberg M, Huebner J. The influence of antioxidant supplementation on adverse effects and tumor interaction during radiotherapy: a systematic review. Clin Exp Med. 2025 Jul 22;25(1):258. doi: 10.1007/s10238-025-01804-x. PMID: 40691411; PMCID: PMC12279893

Apperley JF, Milojkovic D, Cross NCP, Hjorth-Hansen H, Hochhaus A, Kantarjian H, Lipton JH, Malhotra H, Niederwieser D, Radich J, Rousselot P, Saussele S, Schiffer CA, Silver R, Soverini S, Stenke L, Turkina A, Casado LF, Castagnetti F, Cervantes F, Clark RE, Cortes J, Deininger M, Hughes TP, Janssen J, Jiang Q, Kim DW, Larson RA, Mahon FX, Mauro M, Mayer J, Nicolini FE, Pane F, Rea D, Richter J, Rosti G, Saglio G, Hehlmann R. 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Leukemia. 2025 Aug;39(8):1797-1813. doi: 10.1038/s41375-025-02664-w. Epub 2025 Jul 11. PMID: 40646132

Wolff H, Zomorodbakhsch B, Schnizer M, Keinki C, Hübner J. Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment. J Cancer Res Clin Oncol. 2025 Jul 10;151(7):211. doi: 10.1007/s00432-025-06238-2. PMID: 40634631

Maschmeyer G, Fehm T, Loibl S, Dittrich R, Hilgendorf I. Onkopedia - What's New? Systemic Tumor Treatment in Pregnancy. Oncol Res Treat. 2025 Jul 2:1-25. doi: 10.1159/000547137. Epub ahead of print. PMID: 40602390

Seltmann A, Mayer K, Hahn-Ast C, Brioli A, Rüthrich MM, Brossart P, Hochhaus A, von Lilienfeld-Toal M. Sex-disaggregated analysis of pneumonia in patients with high-risk neutropenia. Oncol Res Treat. 2025 Jun 24:1-14. doi: 10.1159/000546911. Epub ahead of print. PMID: 40555220

Akhtar NM, Walter A, Katenkamp K, Chen Y, Lehmann T, Weschenfelder W, Spiegel C, Vogt M, Hofmann GO, Hochhaus A, Gaßler N, Clement JH and Schrenk KG (2025) MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma. Front. Oncol. 15:1577859. doi: 10.3389/fonc.2025.1577859

Weiss M, Hammersen J, Rudolphi S, Formann I, Träger K, Rücker FG, Grüner B, Allgöwer A, Birndt S, Fabisch C, Hochhaus A, Döhner K, La Rosée P, Stegelmann F. l. Prognostic Impact of COVID-19 Inflammation Score Response: A Sub-Group Analysis on Critically Ill Patients of the RuxCoFlam Trial. Life. 2025; 15(5):781. https://doi.org/10.3390/life15050781

Mauro MJ MD, Minami Y, Hochhaus A, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Cortes J, Abdo A, Fogliato LM, Kim DDH, le Coutre P, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Chee L, Garcia-Gutierrez V, Sasaki K, Boquimpani C, Kapoor S, Espurz-Abad N, Dhamal V, Rea D. Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL. Blood Adv. 2025 May 7:bloodadvances.2025016042. doi: 10.1182/bloodadvances.2025016042. Epub ahead of print. PMID: 40334072

Christian Keinki, Mariska-Alenka Klein, Lukas Käsmann, Karsten Münstedt, Jutta Hübner,
Patients’ information on side effects of cancer treatment and usage of complementary and alternative medicine – A cross-sectional study. Advances in Integrative Medicine, 2025, 100497, ISSN 2212-9588,https://doi.org/10.1016/j.aimed.2025.100497. (https://www.sciencedirect.com/science/article/pii/S2212958825000564)

Turkina A, Vinogradova O, Lomaia E, Shatokhina E, Shukhov O, Chelysheva E, Shikhbabaeva D, Nemchenko I, Petrova A, Bykova A, Siordiya N, Shuvaev V, Mikhailov I, Novikov F, Shulgina V, Hochhaus A, Ottmann O, Cortes J, Gale RP, Chilov G. Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia. Ann Hematol. 2025 Apr 29. doi: 10.1007/s00277-025-06239-8. Epub ahead of print. PMID: 4029899

Morath O, Rinke J, Walter A, Crodel C, Meggendorfer M, Baer C, Hochhaus A, Ernst T. Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis. Ann Hematol. 2025 Apr 27. doi: 10.1007/s00277-025-06361-7. Epub ahead of print. PMID: 40287867

Zeremski V, Haage TR, Witte HM, Adolph L, Beer SA, Behre G, Jacobs B, Kahl C, Lalayanni C, Panse J, Papageorgiou S, Siakantaris MP, Schneider J, Schnetzke U, Schulz A, Vassilakopoulos TP, Walter J, Mougiakakos D. PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma. J Hematol Oncol. 2025 Apr 24;18(1):48. doi: 10.1186/s13045-025-01700-7. PMID: 40275355; PMCID: PMC12023625

Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, Boyadzhiev H, Melchardt T, Hölscher AS, Schultze-Florey CR, Abdelhafez A, Velazquez GF, Ossami Saidy A, Lesan V, Schnetzke U, Kerkhoff A, Bacher U, Ghandili S, Aydilek E, Gebauer N, Weber T, Wulf GG, Glass B, Thurner L, Heidel FH, Schmid C, Viardot A, Hänel M, Dietrich S, Pabst T, Ayuk FA, von Tresckow B, Chapuy B, Pott C, Müller F, Lenz G. Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma. Blood Adv. 2025 Apr 16:bloodadvances.2024015719. doi: 10.1182/bloodadvances.2024015719. Epub ahead of print. PMID: 40238938

Nguyen HA, Doerfler J, Buentzel J, Keinki C, Huebner J. Assessing iIndications for herbal medicinal products: a comparative analysis of EMA monographs and database records. BMC Complement Med Ther. 2025 Apr 9;25(1):130. doi: 10.1186/s12906-025-04852-8. PMID: 40205417

Hochhaus A, Kim DW, Cortes JE, Sasaki K, Mauro MJ, Hughes TP, Breccia M, Talpaz M, Minami H, Goh YT, DeAngelo DJ, Lang F, Ottmann O, Heinrich MC, Gomez Garcia de Soria V, le Coutre P, Sanchez-Olle G, Cao M, Pognan N, Kapoor S, Hoch M, Rea D. Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results. Leukemia. 2025 Apr 9. doi: 10.1038/s41375-025-02578-7. Epub ahead of print. PMID: 40204892

Cortes JE, Lang F, Rea D, Hochhaus A, Breccia M, Goh YT, Heinrich MC, Hughes TP, Janssen JJWM, le Coutre P, Minami H, Sasaki K, DeAngelo DJ, Sanchez-Olle G, Pognan N, Cao M, Hoch M, Mauro MJ. Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results. Leukemia. 2025 Apr 9. doi: 10.1038/s41375-025-02592-9. Epub ahead of print. PMID: 40204896

Heyder C, Büntzel J, Boyadzhiev H, Stegmaier P, Zomorodbakhsch B, Heißner K, Stoll C, von Weikersthal LF, Czekay J, Rudolph I, Hübner J. Does anxiety influence the use of complementary or alternative medicine among cancer patients? J Cancer Res Clin Oncol. 2025 Mar 26;151(3):123. doi: 10.1007/s00432-025-06173-2. PMID: 4013367

Ruhnke L, Bill M, Zukunft S, Eckardt JN, Schäfer S, Stasik S, Hanoun M, Schroeder T, Fransecky L, Steffen B, Krause SW, Scholl S, Hochhaus A, Sauer T, Kraus S, Schäfer-Eckart K, Kaufmann M, Jost E, Brümmendorf T, Schliemann C, Mikesch JH, Krug U, Hänel M, Morgner A, Schaich M, Neubauer A, Repp R, Niemann D, Seggewiss-Bernhardt R, Meinhardt A, Kullmer J, Kaiser U, Blau W, Kiani A, Grigoleit GU, Giagounidis A, Wurm AA, Altmann H, Middeke JM, Schetelig J, Müller-Tidow C, Stölzel F, Baldus CD, Platzbecker U, Serve H, Bornhäuser M, Thiede C, Röllig C. Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia. Blood Adv. 2025 Mar 25;9(6):1392-1404. doi: 10.1182/bloodadvances.2024013304. PMID: 39504561

Fosså, A., Molin, D., Bröckelmann, P.J., Schneider, G., Schnetzke, U., Linderoth, J., Kamper, P.M.H., Leppä, S.M., Meissner, J., Schaub, V., Lia, K., Fuchs, M., Borchmann, P. and Böll, B. (2025), Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial. HemaSphere, 9: e70099. https://doi.org/10.1002/hem3.70099

Zibrova D, Ernst T, Hochhaus A, Heller R. The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling. Mol Cell Biochem. 2025 Mar;480(3):1627-1643. doi: 10.1007/s11010-024-05070-5. Epub 2024 Jul 15. PMID: 39009935; PMCID: PMC11842422

Jahns L, Hübner J, Mensger C, Mathies V. A Neutropenic Diet in Haemato-Oncological Patients Receiving High-Dose Therapy and Hematopoietic Stem Cell Transplantation: A Systematic Review. Nutrients. 2025; 17(5):768. https://doi.org/10.3390/nu17050768

Ruhe S, Orawa H, Huebner J, Büntzel J. Hidden Resources for Cancer Patients - Interactions between spirituality, religiosity and selected factors influencing patient's self-care. Oncology. 2025 Feb 3:1-27. doi: 10.1159/000543312. Epub ahead of print. PMID: 39900005

Nicole Erickson, Virpi Sulosaari, Erin Stella Sullivan, Alessandro Laviano, Annemieke van Ginkel-Res, Wineke Remijnse, Joost Wesseling, Ute Koepcke, Nina Weber, Jutta Huebner, Viktoria Mathies, Sebastian Theurich, Theres Fey: Nutrition Care in Cancer: An Overlooked Part of Patient-Centered Care, Seminars in Oncology Nursing, Volume 41, Issue 1, 2025, 151799, ISSN 0749-2081, https://doi.org/10.1016/j.soncn.2024.151799

Fleischmann M, Jentzsch M, Brioli A, Eisele F, Frietsch JJ, Eigendorff F, Tober R, Schrenk KG, Hammersen JF, Yomade O, Hilgendorf I, Hochhaus A, Scholl S, Schnetzke U. Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia. Ann Hematol. 2024 Oct 25. doi: 10.1007/s00277-024-06048-5. Epub ahead of print. Erratum in: Ann Hematol. 2024 Dec;103(12):6061. doi: 10.1007/s00277-024-06095-y. PMID: 39453477

Rötzer, I., Frank, M., von Grundherr, J. et al. Ernährungstherapeutische Besonderheiten bei Patienten mit einem Magenkarzinom. Onkologie 31, 206–212 (2025). https://doi.org/10.1007/s00761-024-01633-9

Gale RP, Hochhaus A. Mpox in people with haematological cancers. Leukemia. 2025 Feb;39(2):275. doi: 10.1038/s41375-024-02465-7. Epub 2024 Dec 13. PMID: 39672828

Röllig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Hänel M, Noppeney R, Hanoun M, Kaufmann M, Weinbergerova B, Schäfer-Eckart K, Sauer T, Neubauer A, Burchert A, Baldus CD, Mertová J, Jost E, Niemann D, Novák J, Krause SW, Scholl S, Hochhaus A, Held G, Szotkowski T, Rank A, Schmid C, Fransecky L, Kayser S, Schaich M, Kramer M, Fiebig F, Haake A, Schetelig J, Middeke JM, Stölzel F, Platzbecker U, Thiede C, Müller-Tidow C, Berdel WE, Ehninger G, Mayer J, Serve H, Bornhäuser M. Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia. J Clin Oncol. 2025 Jan;43(1):65-74. doi: 10.1200/JCO.24.00235. Epub 2024 Sep 16. PMID: 39284116

Xiong L, Beyer D, Liu N, Lehmann T, Neugebauer S, Schaeuble S, Sommerfeld O, Ernst P, Svensson CM, Nietzsche S, Scholl S, Bruns T, Gaßler N, Gräler MH, Figge MT, Panagiotou G, Bauer M, Press AT. Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models. Pharmacol Res. 2025 Jan 4;212:107581. doi: 10.1016/j.phrs.2025.107581. Epub ahead of print. PMID: 39761839

Meren SS, Josfeld L, Bahlmann JC, Fischer von Weikersthal L, Männle H, Huebner J. Feelings of guilt among cancer patients and the usage of complementary or alternative medicine - A cross-sectional survey. Palliat Support Care. 2025 Jan 20;23:e21. doi: 10.1017/S1478951524001718. PMID: 39829247

Erickson N, Sulosaari V, Sullivan ES, Laviano A, van Ginkel-Res A, Remijnse W, Wesseling J, Koepcke U, Weber N, Huebner J, Mathies V, Theurich S, Fey T. Nutrition Care in Cancer: An Overlooked Part of Patient-Centered Care. Semin Oncol Nurs. 2025 Jan 10:151799. doi: 10.1016/j.soncn.2024.151799. Epub ahead of print. PMID: 39799089

Hübner J. Was können und müssen wir aus den Erfolgsgeschichten der Alternativen Medizin lernen; in Lessau M. Riechers H.C. (Hrsg.): Überzeugungskräfte; über das Vertrauen in Wissenschaft (und Pseudowissenschaft); Brill/Fink 2025

Moulis G, Chen F, Carli G, Ghanima W, Trautmann-Grill K, Stauch T, Schifferli A, Miah H, Rueter M, Ghiotto L, Tomasello R, Georgi A, McDonald V, Zaja F, Pettersen HH, Kühne T, Lozano ML, González-López TJ, Provan D, Michel M, Cooper N, Rodeghiero F. Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries. Haematologica. 2025 Dec 1;110(12):3094-3098. doi: 10.3324/haematol.2025.287408. Epub 2025 Jun 26. PMID: 40568720; PMCID: PMC12666275